References

A peer-reviewed open-access article examining the global burden of insufficient sleep and its public health consequences. Available freely via PubMed Central using PMCID: PMC6473877.

A cross-country economic analysis covering the USA, UK, Germany, Japan, and Canada. The UK figure of up to £40 billion reflects the estimated annual GDP loss attributable to insufficient sleep, including costs from absenteeism and reduced productivity. Note: this figure reflects the broader economic cost of sleep loss and is not limited to diagnosed sleep disorders.

A clinical review providing guidance on the assessment and management of sleep problems in children. Estimates the prevalence of sleep difficulties in children aged 3–12 years at 15–30%.

An evidence-based briefing for UK parliamentarians drawing on peer-reviewed research and expert interviews. Identifies insomnia as one of the two most common sleep-wake disorders presenting to clinicians in the UK, affecting between 6–40% of the population depending on definition, and confirms it is the most prevalent sleep disorder seen in primary care.

A systematic meta-analysis of epidemiological studies examining the relationship between insomnia and cardiovascular disease risk. Found that insomnia is associated with a 45% increased risk of developing or dying from cardiovascular disease.

A meta-analysis of longitudinal epidemiological studies demonstrating that insomnia significantly increases the risk of developing depression. People with insomnia have approximately twice the risk of developing depression compared to those without sleep difficulties.

A systematic review and meta-analysis found that approximately 70% of migraine sufferers experience insomnia, demonstrating a significant bidirectional relationship between migraine and sleep disturbance.

Migraine affects approximately 1 in 3 women in the UK, making it one of the most prevalent neurological conditions disproportionately affecting women.

A 2025 study published in npj Dementia examining the relationship between sleep disturbances and subsequent neurodegenerative disease. Findings indicate that sleep disorders may impart measurable risk up to 15 years before the clinical onset of neurodegenerative conditions such as Parkinson's disease and dementia.

Large-scale survey data demonstrating that the majority of adolescents fail to achieve recommended sleep durations, with significant implications for academic performance, mental health, and metabolic health.

A comprehensive clinical review reporting that up to 75% of children and young people with neurodevelopmental, emotional, behavioural and intellectual disorders experience significant sleep problems, including insomnia and sleep maintenance difficulties, with wide-ranging impact on behaviour, cognition, and academic performance.

A landmark meta-analysis synthesising 86 studies involving 35,936 school-age children (5–12 years), demonstrating consistent associations between sleep duration, cognitive performance, and behavioural difficulties. Better sleep was significantly associated with better cognitive performance and fewer behavioural problems across multiple domains including executive function, school performance, and emotional regulation.

AASM consensus statement providing evidence-based sleep duration recommendations for children and adolescents across different age groups.

A comprehensive open-access review covering common sleep disorders during pregnancy including insomnia, obstructive sleep apnoea, restless legs syndrome and circadian rhythm disorders. The paper discusses their prevalence, risk factors and contribution to adverse maternal and fetal outcomes including gestational diabetes, hypertension and preterm birth.

A 2025 open-access narrative review describing the prevalence and pathogenesis of sleep disorders during the menopausal transition. The review reports that sleep disorders affect 16–47% of perimenopausal women, rising to 35–60% in postmenopausal women. Frequent and early awakenings, difficulty falling asleep and interrupted sleep are identified as hallmarks, driven by vasomotor symptoms, hormonal changes and mood disturbance. The review covers insomnia, sleep-related breathing disorders and movement disorders, and discusses pharmacological and non-pharmacological treatment options.

Open-access review demonstrating that circadian disruption associated with shift work is a risk factor for cardiovascular disease, diabetes, obesity, hypertension and metabolic disorders. Meta-analyses cited in the paper show shift workers are approximately 23% more likely to be overweight or obese, carry a 14% increased risk of incident diabetes, and have 11–35% increased odds of metabolic syndrome.

Meta-analysis of longitudinal studies demonstrating that shift work is significantly associated with increased risk of depressive symptoms, anxiety and poor mental health. Altered sleep patterns from shift work were associated with irritability, depressed mood, anxiety and nervousness, with female shift workers at particular risk of poor psychological wellbeing.

A clinical review of insomnia in older adults reporting that up to 50% of this population experience significant sleep difficulties, including problems with sleep onset, maintenance and early morning waking. The review discusses the multifactorial aetiology of insomnia in older adults, including comorbid medical and psychiatric conditions, polypharmacy, and changes in circadian rhythm associated with ageing.

Open-access systematic review and meta-analysis demonstrating that both benzodiazepines (RR 1.52) and Z-drugs (RR 1.90) significantly increase hip fracture risk in older adults. Critically, short-term use carried the greatest risk, with Z-drugs associated with a 2.39-fold increased risk of hip fracture even in new users — directly challenging the assumption that short-term prescribing is safe in this population.

Systematic review and meta-analysis of 55 studies involving 22,780 participants. The pooled prevalence of clinically significant sleep disturbance in people with dementia living in care homes was 20% (1 in 5), based on validated questionnaire measures. The authors note that actigraphy-based thresholds should be interpreted with caution in older populations given normal age-related changes in sleep architecture.

A cross-sectional population-based study of primary care prescribing data examining benzodiazepine and Z-drug prescribing in older adults in Scotland. The study found that care home residents were approximately three times more likely to be prescribed one or more benzodiazepines or Z-drugs compared with community-dwelling older adults, highlighting significant concerns about the appropriateness of hypnotic prescribing in residential care settings.